CCR5 Expression Levels in HIV-Uninfected Women Receiving Hormonal Contraception (Q36149013)

12 August 2017

CCR5 Expression Levels in HIV-Uninfected Women Receiving Hormonal Contraception (English)

1 reference

12 August 2017

1 reference

4

Kathryn Anastos

1 reference

12 August 2017

12

Galit Alter

1 reference

12 August 2017

11

D Heather Watts

1 reference

12 August 2017

9

Mardge Cohen

1 reference

12 August 2017

10

Elizabeth T Golub

1 reference

12 August 2017

Gaia Sciaranghella

1

1 reference

12 August 2017

Cuiwei Wang

2

1 reference

12 August 2017

Haihong Hu

3

1 reference

12 August 2017

Zaher Merhi

5

1 reference

12 August 2017

Marek Nowicki

6

1 reference

12 August 2017

Frank Z Stanczyk

7

1 reference

12 August 2017

Ruth M Greenblatt

8

1 reference

12 August 2017

Mary A Young

13

1 reference

12 August 2017

Athe M N Tsibris

14

1 reference

12 August 2017

language of work or name

English

0 references

publication date

20 April 2015

1 reference

Journal of Infectious Diseases

12 August 2017

1 reference

12 August 2017

212

1 reference

12 August 2017

9

1 reference

12 August 2017

1397-1401

1 reference

Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4601918

Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4601918

Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4601918

Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4601918

A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4601918

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4601918

The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4601918

Differences in the fitness of two diverse wild-type human immunodeficiency virus type 1 isolates are related to the efficiency of cell binding and entry

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4601918

Kinetic factors control efficiencies of cell entry, efficacies of entry inhibitors, and mechanisms of adaptation of human immunodeficiency virus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4601918

Human immunodeficiency virus type 1 (HIV-1) diversity at time of infection is not restricted to certain risk groups or specific HIV-1 subtypes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4601918

Role of the human immunodeficiency virus type 1 envelope gene in viral fitness.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4601918

Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4601918

Radioimmunoassay of serum d-norgestrel in women following oral and intravaginal administration

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4601918

Radioimmunoassay of serum medroxyprogesterone acetate (Provera ®) in women following oral and intravaginal administration

2 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25895986

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Quantitative levonorgestrel plasma level measurements in patients with regular and prolonged use of the levonorgestrel-releasing intrauterine system

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25895986

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/INFDIS/JIV233

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

25895986

1 reference